首頁 > 市場調查報告書 > 消費品

健康美容化妝品

市場調查報告書

商品編碼

2102398

皮膚微生物組護理產品市場：預測至2034年－按產品類型、成分類型、皮膚類型、通路、應用和地區分類的全球分析

Skin Microbiome Care Products Market Forecasts to 2034 - Global Analysis By Product Type, Ingredient Type, Skin Type, Distribution Channel, Application and By Geography

出版日期: 2026年07月11日 | 出版商:

Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

根據 Stratistics MRC 的數據，預計到 2026 年，全球皮膚微生物組護理產品市場規模將達到 85 億美元，並在預測期內以 12.5% 的複合年成長率成長，到 2034 年將達到 173 億美元。

皮膚微生物組護理產品是指專門設計用於支持、維持或修復人體皮膚上天然微生物群落的化妝品和皮膚科配方，而不是破壞或殺死皮膚的生態系統。這些產品包括含有活性或裂解有益菌株的益生菌護膚品、滋養現有共生微生物的益生元配方、含有微生物代謝產物（如短鏈脂肪酸和抗菌肽）的後生元產品、發酵複合物以及不會破壞皮膚酸性屏障的親膚植物萃取物。這項技術融合了微生物學、皮膚病學和化妝品科學，旨在開發能夠維持微生物多樣性、強化皮膚屏障、調節免疫反應並預防腸道菌叢失衡相關症狀的產品。

擴大科學支持

越來越多的臨床研究表明，皮膚微生物群組成在皮膚健康中起著至關重要的作用，這增強了消費者和專業人士對以微生物群為目標的護膚產品的信心。同行評審的研究已明確證實微生物失衡與痤瘡、濕疹、銀屑病和皮膚早衰等疾病之間存在關聯。皮膚科醫師也擴大推薦以微生物群為導向的產品作為敏感肌膚疾病的輔助性治療或主要治療方案。領先的化妝品品牌正在投資進行自身的微生物群研究項目，並與學術機構合作開發實證配方。這種科學支持正將皮膚微生物群護理從單純的行銷概念轉變為一個具有臨床可信度的護膚類，使其能夠獲得高價位和專業人士的認可。

與藥物製劑穩定性相關的挑戰

將活性益生菌、敏感的益生元化合物和生物活性後生元整合到穩定的化妝品配方中，面臨巨大的技術挑戰，限制了產品開發和保存期限的可靠性。活性菌株需要特殊的包埋、溫度控制和儲存系統，才能在生產、分銷和消費者使用過程中維持活性。許多傳統的化妝品防腐劑雖然能確保產品安全，但本身就具有抗菌特性，因此與支持微生物群的作用不相容。微生物組成穩定性所需的pH值通常與其他多功能產品中活性成分的最佳pH範圍相衝突。這些配方穩定性方面的挑戰增加了研發成本，並限制了可用於微生物群護理的產品形態選擇。

個人化微生物組護膚

家用皮膚微生物組檢測和人工智慧驅動的個人化護膚推薦平台的出現，為客製化微生物組護理產品創造了突破性的機遇，這些產品能夠根據個人微生物譜量身定做。消費者現在只需採集皮膚樣本，即可獲得其獨特細菌組成的詳細分析，從而能夠精準選擇針對特定腸道微生物失衡（菌叢失調）模式的產品。個人化配方可以解決個體化的失衡問題，而非使用通用的益生菌和益生元。直接面對消費者（DTC）的微生物組檢測服務正在開闢新的分銷管道，繞過傳統零售，將消費者直接連接到客製化產品的訂閱服務。這種個人化能力正在推動皮膚微生物組護理從大眾市場護膚轉向精準皮膚病學解決方案。

監理風險：誤導性廣告

美國、歐盟和亞太地區的監管機構正在加強對化妝品中與微生物組相關的健康聲明的審查，這給誇大益生菌和益生元成分臨床功效的品牌帶來了法律風險。對於針對特定皮膚問題的微生物組產品而言，化妝品和藥品功效聲明之間的界線尤其模糊。由於不同司法管轄區對化妝品中益生菌的監管定義缺乏統一標準，全球品牌的合規性面臨挑戰。消費者保護組織正在積極監測並質疑未經證實的微生物組相關行銷聲明。應對這些誇大宣傳帶來的監管風險需要低調的行銷策略、詳盡的臨床證據以及嚴格的法律審查流程，這將導致產品上市時間延長，並降低其競爭靈活性。

新型冠狀病毒（COVID-19）的影響：

新冠疫情擾亂了皮膚微生物組護理產品的研發進度和臨床研究項目，同時也加速了消費者對皮膚健康和屏障功能的關注。經常使用洗手液和佩戴口罩損害了皮膚屏障功能，破壞了微生物平衡，從而催生了對親膚修復產品的新需求。疫情後的恢復階段，人們對皮膚健康科學的興趣持續高漲，並開始拋棄刺激性強的抗菌護膚方法。居家隔離期間養成的護膚習慣促進了專業微生物組產品的使用。長期來看，疫情帶來的結構性影響包括：人們對皮膚屏障健康的認知持續增強，以及消費者對溫和、尊重微生物組的配方而非強效抗菌產品的強烈偏好。

在預測期內，保濕霜和乳霜細分市場預計將佔據最大的市場佔有率。

由於保濕霜和乳霜是日常必需品，消費者對其認知度高，且與神經醯胺、脂肪酸和屏障修復化合物等有益於微生物群的成分具有良好的兼容性，預計在預測期內，保濕霜和乳霜細分市場將佔據最大的市場佔有率。保濕霜是輸送益生元纖維、後生元萃取物和有益於微生物群的潤膚劑的主要載體，這些成分能夠強化角質層，同時支持共生菌群的生長。領先的護膚品牌正在推出專門針對敏感或不穩定膚質人群的、注重微生物群的保濕產品系列。終端用戶之所以青睞這類產品，是因為它們只需每天使用一次，即可同時達到保濕和支持微生物生態系統的雙重功效。與偶爾使用的產品類型相比，該細分市場具有較高的複購率和更高的定價潛力。

預計在預測期內，後生元領域將錄得最高的複合年成長率。

在預測期內，後生元領域預計將呈現最高的成長率，這主要得益於其配方穩定性優於活性益生菌、生物活性功效的強力臨床證據，以及化妝品中活性微生物成分監管的不確定性。抗菌肽、有機酸和胞外多醣等後生元化合物能夠調節微生物群，且不會像活性益生菌護膚那樣面臨活性挑戰。後生元原料的生產具有規模化優勢，隨著產量的增加，可確保穩定的供應並降低成本。在主要市場，後生元作為化妝品成分的法規核准已相當完善，合規障礙也已消除。主要原料供應商正在擴大其後生元產能，以滿足全球護膚製造商日益成長的需求。

市佔率最大的地區：

在預測期內，北美預計將佔據最大的市場佔有率，這主要得益於其先進的皮膚病學研究基礎設施、消費者在高階護膚上的高支出，以及強大的D2C（直接面對消費者）品牌生態系統，這些都為提升消費者對微生物組的認知和產品分銷提供了支持。美國是該地區需求的主要驅動力，擁有數量最多的專注於微生物組的護膚新創公司和投資於微生物科學的成熟美妝品牌。歐萊雅、雅詩蘭黛和強生等領導企業正在進行大規模的皮膚微生物組科學研發計畫。化妝品法律規範為關注微生物組的產品的功效聲明提供了明確的指南。此外，該地區成熟的電子商務和訂閱模式也促進了專業微生物組護理產品的試用和持續使用。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率，這主要得益於中國、日本、韓國和東南亞地區日益增強的美容意識、對生物技術和發酵科學投資的增加，以及對循證護膚方案不斷成長的需求。韓國先進的美容創新生態系統正引領以微生物組為導向的發酵護膚成分的研發。在中國，龐大且不斷成長的中產階級越來越接受以科學研究為支撐的高階護膚理念。在日本，悠久的發酵美容成分使用傳統和深厚的文化親和性正在加速微生物組護理概念的普及。此外，政府對生物技術和化妝品科學研究的支持，也為國內微生物組護膚產業的發展奠定了製度基礎。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

企業概況
- 對其他市場參與者（最多 3 家公司）進行全面分析
- 對主要公司進行SWOT分析（最多3家公司）
區域細分
- 根據客戶要求，我們可以提供主要國家的市場估算和預測，以及複合年成長率（註：需進行可行性評估）。
競爭性標竿分析
- 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

北美洲
- 美國
- 加拿大
- 墨西哥
歐洲
- 英國
- 德國
- 法國
- 義大利
- 西班牙
- 荷蘭
- 比利時
- 瑞典
- 瑞士
- 波蘭
- 其他歐洲國家
亞太地區
- 中國
- 日本
- 印度
- 韓國
- 澳洲
- 印尼
- 泰國
- 馬來西亞
- 新加坡
- 越南
- 其他亞太國家
南美洲
- 巴西
- 阿根廷
- 哥倫比亞
- 智利
- 秘魯
- 其他南美國家
世界其他地區（RoW）
- 中東
  - 沙烏地阿拉伯
  - 阿拉伯聯合大公國
  - 卡達
  - 以色列
  - 其他中東國家
- 非洲
  - 南非
  - 埃及
  - 摩洛哥
  - 其他非洲國家

第11章策略市場資訊

工業價值網路和供應鏈評估
空白區域和機會地圖
產品演進與市場生命週期分析
通路、經銷商和打入市場策略的評估

第12章產業趨勢與策略舉措

併購
夥伴關係、聯盟和合資企業
新產品發布和認證
擴大生產能力和投資
其他策略舉措

第13章：公司簡介

L'Oreal SA
NAOS Group
The Estee Lauder Companies Inc.
Unilever PLC
Shiseido Company, Limited
Beiersdorf AG
Gallinee Ltd.
Esse Skincare
Glowbiotics Inc.
The Clorox Company（Burt's Bees）
Johnson & Johnson
Codex Beauty Labs
LaFlore Probiotic Skincare
Aurelia London
Procter & Gamble Company
Amorepacific Corporation
Colgate-Palmolive Company

簡介目錄圖表

Product Code: SMRC38274

According to Stratistics MRC, the Global Skin Microbiome Care Products Market is accounted for $8.5 billion in 2026 and is expected to reach $17.3 billion by 2034 growing at a CAGR of 12.5% during the forecast period. Skin microbiome care products refer to cosmetic and dermatological formulations specifically designed to support, preserve, or restore the natural community of microorganisms residing on human skin rather than stripping or sterilizing the cutaneous ecosystem. These products encompass probiotic skincare containing live or lysed beneficial bacterial strains, prebiotic formulations that nourish existing commensal microbes, postbiotic products incorporating microbial metabolites such as short-chain fatty acids and antimicrobial peptides, fermented ingredient complexes, and microbiome-friendly botanical extracts that avoid disrupting the skin's acid mantle. The technology integrates microbiology, dermatology, and cosmetic science to develop products that maintain microbial diversity, strengthen the skin barrier, modulate immune responses, and prevent dysbiosis-associated conditions.

Market Dynamics:

Driver:

Scientific validation growth

Expanding clinical research demonstrating the critical role of skin microbiome composition in dermatological health is driving consumer and professional confidence in microbiome-targeted skincare products. Peer-reviewed studies have established clear links between microbial dysbiosis and conditions including acne, eczema, psoriasis, and premature aging. Dermatologists are increasingly recommending microbiome-friendly products as adjunct or primary treatments for sensitive skin conditions. Major beauty brands have invested in proprietary microbiome research programs and partnerships with academic institutions to develop evidence-based formulations. This scientific validation transforms skin microbiome care from a marketing concept into a clinically credible skincare category that commands premium pricing and professional endorsement.

Restraint:

Formulation stability challenges

The incorporation of live probiotics, sensitive prebiotic compounds, and bioactive postbiotics into stable cosmetic formulations presents significant technical challenges that constrain product development and shelf-life reliability. Live bacterial strains require specialized encapsulation, temperature control, and preservation systems to maintain viability throughout manufacturing, distribution, and consumer use. Many conventional cosmetic preservatives that ensure product safety are inherently antimicrobial and therefore incompatible with microbiome-supportive positioning. pH requirements for microbial ingredient stability frequently conflict with optimal pH ranges for other active ingredients in multi-functional products. These formulation stability challenges increase research and development costs and limit the range of viable product formats for microbiome care applications.

Opportunity:

Personalized microbiome skincare

The emergence of at-home skin microbiome testing and AI-driven personalized skincare recommendation platforms unlocks transformative opportunities for customized microbiome care products tailored to individual microbial profiles. Consumers can now swab their skin and receive detailed analysis of their unique bacterial composition, enabling targeted product selection for specific dysbiosis patterns. Personalized formulations can address individual imbalances rather than applying generic probiotic or prebiotic products. Direct-to-consumer microbiome testing services are creating new distribution channels that bypass traditional retail and connect consumers directly with customized product subscriptions. These personalization capabilities elevate skin microbiome care from mass-market skincare to precision dermatology solutions.

Threat:

Overclaim enforcement risk

Regulatory agencies in the United States, European Union, and Asia Pacific are intensifying scrutiny of microbiome-related health claims on cosmetic products, creating enforcement risks for brands that overstate the clinical benefits of probiotic and prebiotic ingredients. The line between cosmetic claims and drug claims is particularly blurred for microbiome products targeting specific skin conditions. Inconsistent regulatory definitions of probiotics in cosmetics across jurisdictions create compliance complexity for global brands. Consumer protection organizations are actively monitoring and challenging unsubstantiated microbiome marketing claims. This overclaim enforcement risk necessitates conservative marketing language, extensive clinical substantiation, and legal review processes that increase time-to-market and reduce competitive agility.

Covid-19 Impact:

The COVID-19 pandemic disrupted skin microbiome care product development timelines and clinical research programs while simultaneously accelerating consumer interest in skin health and barrier function. Frequent hand sanitizing and mask-wearing damaged skin barriers and disrupted microbial balance, creating new demand for microbiome-friendly repair products. Post-pandemic recovery has been characterized by sustained interest in skin health science and rejection of harsh antimicrobial skincare approaches. The shift toward at-home skincare routines during lockdowns expanded trial of specialized microbiome products. The long-term structural impact includes permanent elevation of skin barrier health awareness and stronger consumer preference for gentle, microbiome-respecting formulations over aggressive antibacterial approaches.

The moisturizers and creams segment is expected to be the largest during the forecast period

The moisturizers and creams segment is expected to account for the largest market share during the forecast period, due to their universal daily use requirement, broad consumer familiarity, and optimal formulation compatibility with microbiome-supportive ingredients such as ceramides, fatty acids, and barrier-repairing compounds. Moisturizers serve as the primary vehicle for delivering prebiotic fibers, postbiotic extracts, and microbiome-friendly emollients that strengthen the stratum corneum while supporting commensal bacterial populations. Major skincare brands have launched dedicated microbiome-friendly moisturizer lines targeting sensitive and compromised skin conditions. End-user adoption is driven by the dual benefit of hydration and microbial ecosystem support in a single daily application. The segment benefits from higher repeat purchase rates and premium pricing power compared to occasional-use product categories.

The postbiotics segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the postbiotics segment is predicted to witness the highest growth rate, driven by their superior formulation stability compared to live probiotics, strong clinical evidence of bioactive efficacy, and absence of regulatory ambiguity surrounding live microbial ingredients in cosmetics. Postbiotic compounds including antimicrobial peptides, organic acids, and exopolysaccharides deliver microbiome-modulating benefits without the viability challenges that constrain live probiotic skincare. The scalability of postbiotic ingredient production enables consistent supply and cost reduction as manufacturing volumes increase. Regulatory acceptance of postbiotics as cosmetic ingredients is well-established across major markets, removing compliance barriers. Major ingredient suppliers have expanded postbiotic production capacity to meet accelerating demand from global skincare manufacturers.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, due to advanced dermatological research infrastructure, high consumer spending on premium skincare, and strong direct-to-consumer brand ecosystems that support microbiome education and product distribution. The United States leads regional demand with the highest concentration of microbiome-focused skincare startups and established beauty brands investing in microbial science. Major players including L'Oreal, The Estee Lauder Companies, and Johnson & Johnson maintain significant research and development programs in skin microbiome science. Regulatory frameworks for cosmetics provide clear pathways for microbiome-friendly product claims. The region's sophisticated e-commerce and subscription models facilitate trial and retention of specialized microbiome care products.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, due to expanding beauty consciousness, growing investment in biotechnology and fermentation science, and rising demand for science-backed skincare solutions across China, Japan, South Korea, and Southeast Asia. South Korea's advanced beauty innovation ecosystem is pioneering microbiome-friendly fermentation-based skincare ingredients. China's large and growing middle class is increasingly receptive to premium skincare concepts backed by scientific research. Japan's long tradition of fermented beauty ingredients provides cultural familiarity that accelerates microbiome care adoption. Government support for biotechnology and cosmetic science research creates institutional foundations for domestic microbiome skincare industry development.

Key players in the market

Some of the key players in Skin Microbiome Care Products Market include L'Oreal S.A., NAOS Group, The Estee Lauder Companies Inc., Unilever PLC, Shiseido Company, Limited, Beiersdorf AG, Gallinee Ltd., Esse Skincare, Glowbiotics Inc., The Clorox Company (Burt's Bees), Johnson & Johnson, Codex Beauty Labs, LaFlore Probiotic Skincare, Aurelia London, Procter & Gamble Company, Amorepacific Corporation and Colgate-Palmolive Company.

Key Developments:

In June 2026, L'Oreal S.A. launched a proprietary skin microbiome analysis service integrated with its La Roche-Posay brand, enabling consumers to receive personalized skincare recommendations based on their individual cutaneous bacterial profiles.

In May 2026, Gallinee Ltd. introduced a patented postbiotic face cream containing lysed lactobacillus extracts, achieving clinical validation for barrier repair and sensitivity reduction in atopic dermatitis patients.

In April 2026, Unilever PLC expanded its microbiome-friendly skincare research partnership with a leading European university, securing exclusive licensing rights for novel prebiotic oligosaccharide compounds derived from botanical sources.

Product Types Covered:

Cleansers
Moisturizers and Creams
Serums
Masks
Sunscreens
Other Product Types

Ingredient Types Covered:

Probiotics
Prebiotics
Postbiotics
Fermented Ingredients
Microbiome-Friendly Botanical Extracts
Other Ingredient Types

Skin Types Covered:

Normal Skin
Dry Skin
Oily Skin
Combination Skin
Sensitive Skin
Acne-Prone Skin

Distribution Channels Covered:

Supermarkets and Hypermarkets
Pharmacies and Drug Stores
Specialty Beauty Stores
E-Commerce Platforms
Direct-to-Consumer (DTC)
Dermatology Clinics

Applications Covered:

Acne Care
Anti-Aging
Skin Barrier Repair
Hydration and Moisturization
Eczema and Sensitive Skin Care
Daily Skin Wellness

Regions Covered:

North America
- United States
- Canada
- Mexico
Europe
- United Kingdom
- Germany
- France
- Italy
- Spain
- Netherlands
- Belgium
- Sweden
- Switzerland
- Poland
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Vietnam
- Rest of Asia Pacific
South America
- Brazil
- Argentina
- Colombia
- Chile
- Peru
- Rest of South America
Rest of the World (RoW)
- Middle East
Saudi Arabia
United Arab Emirates
Qatar
Israel
Rest of Middle East
- Africa
South Africa
Egypt
Morocco
Rest of Africa

What our report offers:

Market share assessments for the regional and country-level segments
Strategic recommendations for the new entrants
Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary

1.1 Market Snapshot and Key Highlights
1.2 Growth Drivers, Challenges, and Opportunities
1.3 Competitive Landscape Overview
1.4 Strategic Insights and Recommendations

2 Research Framework

2.1 Study Objectives and Scope
2.2 Stakeholder Analysis
2.3 Research Assumptions and Limitations
2.4 Research Methodology
- 2.4.1 Data Collection (Primary and Secondary)
- 2.4.2 Data Modeling and Estimation Techniques
- 2.4.3 Data Validation and Triangulation
- 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

3.1 Market Definition and Structure
3.2 Key Market Drivers
3.3 Market Restraints and Challenges
3.4 Growth Opportunities and Investment Hotspots
3.5 Industry Threats and Risk Assessment
3.6 Technology and Innovation Landscape
3.7 Emerging and High-Growth Markets
3.8 Regulatory and Policy Environment
3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

4.1 Porter's Five Forces Analysis
- 4.1.1 Supplier Bargaining Power
- 4.1.2 Buyer Bargaining Power
- 4.1.3 Threat of Substitutes
- 4.1.4 Threat of New Entrants
- 4.1.5 Competitive Rivalry
4.2 Market Share Analysis of Key Players
4.3 Product Benchmarking and Performance Comparison

5 Global Skin Microbiome Care Products Market, By Product Type

5.1 Cleansers
5.2 Moisturizers and Creams
5.3 Serums
5.4 Masks
5.5 Sunscreens
5.6 Other Product Types

6 Global Skin Microbiome Care Products Market, By Ingredient Type

6.1 Probiotics
6.2 Prebiotics
6.3 Postbiotics
6.4 Fermented Ingredients
6.5 Microbiome-Friendly Botanical Extracts
6.6 Other Ingredient Types

7 Global Skin Microbiome Care Products Market, By Skin Type

7.1 Normal Skin
7.2 Dry Skin
7.3 Oily Skin
7.4 Combination Skin
7.5 Sensitive Skin
7.6 Acne-Prone Skin

8 Global Skin Microbiome Care Products Market, By Distribution Channel

8.1 Supermarkets and Hypermarkets
8.2 Pharmacies and Drug Stores
8.3 Specialty Beauty Stores
8.4 E-Commerce Platforms
8.5 Direct-to-Consumer (DTC)
8.6 Dermatology Clinics

9 Global Skin Microbiome Care Products Market, By Application

9.1 Acne Care
9.2 Anti-Aging
9.3 Skin Barrier Repair
9.4 Hydration and Moisturization
9.5 Eczema and Sensitive Skin Care
9.6 Daily Skin Wellness

10 Global Skin Microbiome Care Products Market, By Geography

10.1 North America
- 10.1.1 United States
- 10.1.2 Canada
- 10.1.3 Mexico
10.2 Europe
- 10.2.1 United Kingdom
- 10.2.2 Germany
- 10.2.3 France
- 10.2.4 Italy
- 10.2.5 Spain
- 10.2.6 Netherlands
- 10.2.7 Belgium
- 10.2.8 Sweden
- 10.2.9 Switzerland
- 10.2.10 Poland
- 10.2.11 Rest of Europe
10.3 Asia Pacific
- 10.3.1 China
- 10.3.2 Japan
- 10.3.3 India
- 10.3.4 South Korea
- 10.3.5 Australia
- 10.3.6 Indonesia
- 10.3.7 Thailand
- 10.3.8 Malaysia
- 10.3.9 Singapore
- 10.3.10 Vietnam
- 10.3.11 Rest of Asia Pacific
10.4 South America
- 10.4.1 Brazil
- 10.4.2 Argentina
- 10.4.3 Colombia
- 10.4.4 Chile
- 10.4.5 Peru
- 10.4.6 Rest of South America
10.5 Rest of the World (RoW)
- 10.5.1 Middle East
  - 10.5.1.1 Saudi Arabia
  - 10.5.1.2 United Arab Emirates
  - 10.5.1.3 Qatar
  - 10.5.1.4 Israel
  - 10.5.1.5 Rest of Middle East
- 10.5.2 Africa
  - 10.5.2.1 South Africa
  - 10.5.2.2 Egypt
  - 10.5.2.3 Morocco
  - 10.5.2.4 Rest of Africa

11 Strategic Market Intelligence

11.1 Industry Value Network and Supply Chain Assessment
11.2 White-Space and Opportunity Mapping
11.3 Product Evolution and Market Life Cycle Analysis
11.4 Channel, Distributor, and Go-to-Market Assessment

12 Industry Developments and Strategic Initiatives

12.1 Mergers and Acquisitions
12.2 Partnerships, Alliances, and Joint Ventures
12.3 New Product Launches and Certifications
12.4 Capacity Expansion and Investments
12.5 Other Strategic Initiatives

13 Company Profiles

13.1 L'Oreal S.A.
13.2 NAOS Group
13.3 The Estee Lauder Companies Inc.
13.4 Unilever PLC
13.5 Shiseido Company, Limited
13.6 Beiersdorf AG
13.7 Gallinee Ltd.
13.8 Esse Skincare
13.9 Glowbiotics Inc.
13.10 The Clorox Company (Burt's Bees)
13.11 Johnson & Johnson
13.12 Codex Beauty Labs
13.13 LaFlore Probiotic Skincare
13.14 Aurelia London
13.15 Procter & Gamble Company
13.16 Amorepacific Corporation
13.17 Colgate-Palmolive Company

簡介目錄圖表

List of Tables

Table 1 Global Skin Microbiome Care Products Market Outlook, By Region (2023-2034) ($MN)
Table 2 Global Skin Microbiome Care Products Market Outlook, By Product Type (2023-2034) ($MN)
Table 3 Global Skin Microbiome Care Products Market Outlook, By Cleansers (2023-2034) ($MN)
Table 4 Global Skin Microbiome Care Products Market Outlook, By Moisturizers and Creams (2023-2034) ($MN)
Table 5 Global Skin Microbiome Care Products Market Outlook, By Serums (2023-2034) ($MN)
Table 6 Global Skin Microbiome Care Products Market Outlook, By Masks (2023-2034) ($MN)
Table 7 Global Skin Microbiome Care Products Market Outlook, By Sunscreens (2023-2034) ($MN)
Table 8 Global Skin Microbiome Care Products Market Outlook, By Other Product Types (2023-2034) ($MN)
Table 9 Global Skin Microbiome Care Products Market Outlook, By Ingredient Type (2023-2034) ($MN)
Table 10 Global Skin Microbiome Care Products Market Outlook, By Probiotics (2023-2034) ($MN)
Table 11 Global Skin Microbiome Care Products Market Outlook, By Prebiotics (2023-2034) ($MN)
Table 12 Global Skin Microbiome Care Products Market Outlook, By Postbiotics (2023-2034) ($MN)
Table 13 Global Skin Microbiome Care Products Market Outlook, By Fermented Ingredients (2023-2034) ($MN)
Table 14 Global Skin Microbiome Care Products Market Outlook, By Microbiome-Friendly Botanical Extracts (2023-2034) ($MN)
Table 15 Global Skin Microbiome Care Products Market Outlook, By Other Ingredient Types (2023-2034) ($MN)
Table 16 Global Skin Microbiome Care Products Market Outlook, By Skin Type (2023-2034) ($MN)
Table 17 Global Skin Microbiome Care Products Market Outlook, By Normal Skin (2023-2034) ($MN)
Table 18 Global Skin Microbiome Care Products Market Outlook, By Dry Skin (2023-2034) ($MN)
Table 19 Global Skin Microbiome Care Products Market Outlook, By Oily Skin (2023-2034) ($MN)
Table 20 Global Skin Microbiome Care Products Market Outlook, By Combination Skin (2023-2034) ($MN)
Table 21 Global Skin Microbiome Care Products Market Outlook, By Sensitive Skin (2023-2034) ($MN)
Table 22 Global Skin Microbiome Care Products Market Outlook, By Acne-Prone Skin (2023-2034) ($MN)
Table 23 Global Skin Microbiome Care Products Market Outlook, By Distribution Channel (2023-2034) ($MN)
Table 24 Global Skin Microbiome Care Products Market Outlook, By Supermarkets and Hypermarkets (2023-2034) ($MN)
Table 25 Global Skin Microbiome Care Products Market Outlook, By Pharmacies and Drug Stores (2023-2034) ($MN)
Table 26 Global Skin Microbiome Care Products Market Outlook, By Specialty Beauty Stores (2023-2034) ($MN)
Table 27 Global Skin Microbiome Care Products Market Outlook, By E-Commerce Platforms (2023-2034) ($MN)
Table 28 Global Skin Microbiome Care Products Market Outlook, By Direct-to-Consumer (DTC) (2023-2034) ($MN)
Table 29 Global Skin Microbiome Care Products Market Outlook, By Dermatology Clinics (2023-2034) ($MN)
Table 30 Global Skin Microbiome Care Products Market Outlook, By Application (2023-2034) ($MN)
Table 31 Global Skin Microbiome Care Products Market Outlook, By Acne Care (2023-2034) ($MN)
Table 32 Global Skin Microbiome Care Products Market Outlook, By Anti-Aging (2023-2034) ($MN)
Table 33 Global Skin Microbiome Care Products Market Outlook, By Skin Barrier Repair (2023-2034) ($MN)
Table 34 Global Skin Microbiome Care Products Market Outlook, By Hydration and Moisturization (2023-2034) ($MN)
Table 35 Global Skin Microbiome Care Products Market Outlook, By Eczema and Sensitive Skin Care (2023-2034) ($MN)
Table 36 Global Skin Microbiome Care Products Market Outlook, By Daily Skin Wellness (2023-2034) ($MN)